5 takeaways from the abortion pill case before the U.S. Supreme Court
U.S. Supreme Court justices on Tuesday did not appear ready to limit Americans’ access to the abortion pill mifepristone, in a case that could have sweeping implications for how the federal government approves scores of medications
By MATTHEW PERRONE, AMANDA SEITZ and CHRISTINE FERNANDO
Published - Mar 26, 2024, 04:20 PM ET
Last Updated - Mar 26, 2024, 04:20 PM EDT
WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit Americans' access to the abortion pill mifepristone, in a case that could have major implications for the Food and Drug Administration's oversight of thousands of medications.
It's the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
